ALGAE Fermentalg SA

0.4343USD0.3960 EUR · EPA+1.54%Mkt Cap: 51.91M USDP/E: —

Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate …

Key Statistics

Company
Market Cap51.91M USD
Enterprise Value37.59M USD
Revenue (TTM)14.47M USD
Gross Profit2.51M USD
Net Income (TTM)-10.35M USD
Revenue/Share0.14 USD
Last Price0.4343 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees62
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0011271600
Valuation
P/E (Trailing)—
P/E (Forward)-7.18
PEG—
EV/EBITDA-3.99
EV/Revenue2.60
P/S3.59
P/B1.29
EPS (TTM)-0.10 USD
EPS (Forward)-0.06 USD
52W Range
0.384416% of range0.7020
52W High0.7020 USD
52W Low0.3844 USD
Profitability
Gross Margin17.12%
Oper. Margin-82.50%
EBITDA Margin-65.16%
Profit Margin-70.51%
ROE-37.48%
ROA-25.88%
ROIC-47.21%
ROCE-31.66%
Growth
Revenue Growth-2.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.22M USD
CapEx (TTM)1.68M USD
FCF Margin-37.38%
FCF Yield-10.42%
Net Debt-7.52M USD
Net Debt/EBITDA0.80
Net Debt/FCF—
Balance Sheet
Debt/Equity0.05
Current Ratio3.02
Quick Ratio2.78
Book Value/Sh0.34 USD
Cash/Share0.11 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.5429 USD
Upside (mean)+25.0%
Target Range0.4826 USD – 0.6032 USD
0.4826+25.0% to mean0.6032
# Analysts2
Ownership
Shares Out.119.82M
Float67.15M
Insiders15.63%
Institutions17.92%
Technical
SMA 500.4576 (-5.1%)
SMA 2000.5156 (-15.8%)
Beta1.06
S&P 52W Chg12.00%
Avg Vol (30d)93.56K
Avg Vol (10d)139.04K
Technical Indicators
RSI (14)47.7
MACD-0.0027
MACD Signal-0.0050
MACD Hist.+0.0024
BB Upper0.4654 USD
BB Middle0.4318 USD
BB Lower0.3981 USD
BB Width15.57%
ATR (14)0.0248 USD
Vol Ratio (20d)0.26x

About Fermentalg (EPA: ALGAE)

›

Fermentalg (EPA: ALGAE) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 62 employees.

The shares were at 0.3960 EUR on 19 November 2026, down 6.8% over 52 weeks. Its 52-week range is 0.3505 EUR to 0.6400 EUR: the price is 38.1% below the high and 13.0% above the low.

Its market capitalisation is 47.33M EUR.

Fermentalg reports return on equity of -37.5%, an operating margin of -82.5% and revenue down 2.5% year over year.

It holds more cash than debt, a net cash position of 6.85M EUR. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 2 analysts cover the stock; their mean price target of 0.4950 EUR is 25.0% above the current price.